Dr. Erika Young, MD (@drerikayoung) 's Twitter Profile
Dr. Erika Young, MD

@drerikayoung

Board Certified Pediatrician.
Nephrology Fellow.
Broadening horizon of health literacy for patients and families. Proud Meharrian!

ID: 1650134381107838976

calendar_today23-04-2023 13:47:58

13 Tweet

51 Takipçi

81 Takip Edilen

Ben Humphreys (@humphreyslab) 's Twitter Profile Photo

On flight back from JointMeeting, such a delight to sit next to & meet Dr. Lilia Abron, first African-American woman to earn a PhD in chemical engineering, on her way to WashU for the inaugural lectureship in her name. Congratulations Dr. Abron!!

On flight back from <a href="/JointMeeting/">JointMeeting</a>, such a delight to sit next to &amp; meet Dr. Lilia Abron, first African-American woman to earn a PhD in chemical engineering, on her way to <a href="/WUSTL/">WashU</a> for the inaugural lectureship in her name. Congratulations Dr. Abron!!
CJASN (@cjasn) 's Twitter Profile Photo

Fluid overload is the primary reason for admission of patients with acute heart failure. In this Review, Dr Amir Kazory provides an overview of the results of the key studies on combination diuretic therapy in the setting of acute heart failure bit.ly/CJASN0188

Fluid overload is the primary reason for admission of patients with acute heart failure. In this Review, Dr <a href="/AmirKazory/">Amir Kazory</a> provides an overview of the results of the key studies on combination diuretic therapy in the setting of acute heart failure bit.ly/CJASN0188
KDIGO (@gokdigo) 's Twitter Profile Photo

KDIGO is pleased to announce the publication of "International Consensus on Standardized Clinic Blood Pressure Measurement − A Call to Action" in The American Journal of Medicine. Read the News Release: kdigo.co/BP-Standardize… Read the full statement: amjmed.com/article/S0002-…

CJASN (@cjasn) 's Twitter Profile Photo

Clinical trials have demonstrated remarkable benefits of SGLT-2 inhibitors. This collection from JASN_News, CJASN, & ASN Kidney360 highlights rapidly advancing knowledge of SGLT-2 inhibitor benefits, risks, mechanisms of action, and applications bit.ly/ASNSGLT2 #jnlcoll

Clinical trials have demonstrated remarkable benefits of SGLT-2 inhibitors. This collection from <a href="/JASN_News/">JASN_News</a>, CJASN, &amp; <a href="/ASNKidney360/">ASN Kidney360</a> highlights rapidly advancing knowledge of SGLT-2 inhibitor benefits, risks, mechanisms of action, and applications bit.ly/ASNSGLT2 #jnlcoll
Dr. Erika Young, MD (@drerikayoung) 's Twitter Profile Photo

Had a blast at #PAS2023 this year! Met with the amazing members of #ASPN, hung out with my fantastic Pediatric Nephrology co-fellows from around the country, listened to inspiring lectures, and received invaluable career advice from mentors new and old.

Had a blast at #PAS2023 this year! Met with the amazing members of #ASPN, hung out with my fantastic Pediatric Nephrology co-fellows from around the country, listened to  inspiring lectures, and received invaluable career advice from mentors new and old.
NKF Advocacy (@nkf_advocacy) 's Twitter Profile Photo

BREAKING NEWS: 21 new members of the House have just cosponsored the Living Donor Protection Act. This crucial bill will help remove barriers to living donation. Did your legislator sign on? 🧵 #MyKidneyVoice

KDIGO (@gokdigo) 's Twitter Profile Photo

KDIGO is updating the 2021 Glomerular Diseases Guideline on a chapter-by-chapter basis. The KDIGO 2023 ANCA Guideline Update is now available for public review through Monday, May 29. Download the ANCA Guideline Update: kdigo.co/2023-ANCA-Guid… Share your comments via the

KDIGO is updating the 2021 Glomerular Diseases Guideline on a chapter-by-chapter basis. The KDIGO 2023 ANCA Guideline Update is now available for public review through Monday, May 29.

Download the ANCA Guideline Update: kdigo.co/2023-ANCA-Guid…

Share your comments via the